Eran Bendavid
Publication Details
-
The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.
Ann Intern Med. 2012; (8): 541-50
A recent randomized, controlled trial showed that daily oral preexposure chemoprophylaxis (PrEP) was effective for HIV prevention in men who have sex with men (MSM). The Centers for Disease Control and Prevention recently provided interim guidance for PrEP in MSM at high risk for HIV. Previous studies did not reach a consistent estimate of its cost-effectiveness.
Help